|
FR2535721A1
(fr)
|
1982-11-08 |
1984-05-11 |
Sanofi Sa |
Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
JP2518353B2
(ja)
|
1988-06-09 |
1996-07-24 |
住友化学工業株式会社 |
シアノ酢酸アミド誘導体およびその製造中間体
|
|
CA2018801C
(en)
|
1990-06-12 |
2000-08-22 |
Pierre Louis Beaulieu |
Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus
|
|
JPH04177244A
(ja)
|
1990-11-10 |
1992-06-24 |
Konica Corp |
ハロゲン化銀写真感光材料
|
|
CA2033447C
(en)
|
1990-12-31 |
1999-08-31 |
Robert Deziel |
Synergistic combination for treating herpes infections
|
|
DK0495421T3
(da)
|
1991-01-15 |
1996-12-09 |
Alcon Lab Inc |
Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
JPH05301838A
(ja)
|
1991-10-15 |
1993-11-16 |
Mitsubishi Kasei Corp |
スチレン誘導体
|
|
US5792771A
(en)
|
1992-11-13 |
1998-08-11 |
Sugen, Inc. |
Quinazoline compounds and compositions thereof for the treatment of disease
|
|
WO1995024190A2
(en)
|
1994-03-07 |
1995-09-14 |
Sugen, Inc. |
Receptor tyrosine kinase inhibitors for inhibiting cell proliferative disorders and compositions thereof
|
|
JPH0827090A
(ja)
|
1994-05-13 |
1996-01-30 |
Sumitomo Chem Co Ltd |
シアノ酢酸アミド誘導体、その用途およびその製造中間体
|
|
US6331555B1
(en)
|
1995-06-01 |
2001-12-18 |
University Of California |
Treatment of platelet derived growth factor related disorders such as cancers
|
|
PL335839A1
(en)
|
1997-03-14 |
2000-05-22 |
Basf Ag |
Cycloalkylalkane carboxamides as well as their production and application
|
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
|
IL125947A0
(en)
|
1997-09-17 |
1999-04-11 |
American Cyanamid Co |
3-(1,2-benzisothiazol- and isoxazol-5-yl)-2,4(1h,3h)-pyrimidinedione or thione and 3-(1,2-benzisothiazol- and isoxazol-5-yl)-4(3)-pyrimidinone or thione herbicidal agents
|
|
DE69814122T2
(de)
|
1997-10-09 |
2004-03-18 |
Dexcel Pharma Technologies Ltd. |
Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
|
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
|
CA2366932C
(en)
|
1999-04-15 |
2009-08-25 |
Bristol-Myers Squibb Company |
Cyclic protein tyrosine kinase inhibitors
|
|
KR20020088406A
(ko)
|
1999-09-17 |
2002-11-27 |
애보트 게엠베하 운트 콤파니 카게 |
치료제로서의 피라졸로피리미딘
|
|
AU2000240570A1
(en)
|
2000-03-29 |
2001-10-08 |
Knoll Gesellschaft Mit Beschraenkter Haftung |
Pyrrolopyrimidines as tyrosine kinase inhibitors
|
|
AR042586A1
(es)
|
2001-02-15 |
2005-06-29 |
Sugen Inc |
3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
WO2003037890A2
(en)
|
2001-11-01 |
2003-05-08 |
Icagen, Inc. |
Piperidines
|
|
JP3991812B2
(ja)
|
2001-12-11 |
2007-10-17 |
住友化学株式会社 |
エステル化合物およびその用途
|
|
AU2003210983A1
(en)
|
2002-02-11 |
2003-09-04 |
The Brigham And Women's Hospital, Inc. |
Kinase inhibitors and methods of use thereof
|
|
NI200300043A
(es)
|
2002-03-28 |
2003-11-05 |
Warner Lambert Co |
AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.
|
|
FR2842735B1
(fr)
|
2002-07-26 |
2006-01-06 |
Flamel Tech Sa |
Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
|
|
US7419981B2
(en)
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
GB0219024D0
(en)
|
2002-08-15 |
2002-09-25 |
Pfizer Ltd |
Synergistic combinations
|
|
GB0226370D0
(en)
|
2002-11-12 |
2002-12-18 |
Novartis Ag |
Organic compounds
|
|
JP2006518368A
(ja)
|
2003-02-21 |
2006-08-10 |
ファイザー・インク |
プロテインキナーゼ阻害剤としてのn−ヘテロシクリル置換アミノチアゾール誘導体
|
|
WO2004100868A2
(en)
|
2003-04-23 |
2004-11-25 |
Abbott Laboratories |
Method of treating transplant rejection
|
|
JP4727579B2
(ja)
|
2003-08-01 |
2011-07-20 |
中外製薬株式会社 |
マロニル−CoAデカルボキシラーゼ阻害剤として有用なシアノアミド化合物
|
|
KR20060115350A
(ko)
|
2003-09-02 |
2006-11-08 |
화이자 프로덕츠 인크. |
지프라시돈의 지속 방출형 투여 형태
|
|
WO2005023773A1
(en)
|
2003-09-04 |
2005-03-17 |
Pfizer Limited |
Process for the preparation of substituted aryl pyrazoles
|
|
GB0322140D0
(en)
|
2003-09-22 |
2003-10-22 |
Pfizer Ltd |
Combinations
|
|
BRPI0414798A
(pt)
|
2003-09-25 |
2006-11-21 |
Warner Lambert Co |
métodos para usar aminoácidos com afinidade para a proteìna alfa2delta
|
|
WO2005074603A2
(en)
|
2004-02-03 |
2005-08-18 |
Abbott Laboratories |
Aminobenzoxazoles as therapeutic agents
|
|
JP4552456B2
(ja)
|
2004-02-27 |
2010-09-29 |
住友化学株式会社 |
エステル化合物およびその用途
|
|
EP1724264A1
(en)
|
2004-03-10 |
2006-11-22 |
Ono Pharmaceutical Co., Ltd. |
Nitriles and medicinal compositions containing the same as the active ingredient
|
|
US7807719B2
(en)
|
2004-09-14 |
2010-10-05 |
Chaim Roifman |
Compounds useful for modulating abnormal cell proliferation
|
|
US20060079494A1
(en)
|
2004-09-27 |
2006-04-13 |
Santi Daniel V |
Specific kinase inhibitors
|
|
CA2597587A1
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
|
|
US20080260818A1
(en)
|
2005-03-28 |
2008-10-23 |
Dexcel Pharma Technologies Ltd. |
Controlled Absorption of Statins in the Intestine
|
|
EP2029138A1
(en)
|
2005-06-03 |
2009-03-04 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
|
|
US20080146643A1
(en)
|
2005-06-15 |
2008-06-19 |
Pfizer Limited |
Combination
|
|
EP1893581B1
(en)
|
2005-06-15 |
2010-01-27 |
Pfizer Limited |
Substituted arylpyrazoles for use against parasitites
|
|
US20070149464A1
(en)
|
2005-06-15 |
2007-06-28 |
Pfizer Inc. |
Combination
|
|
US7645786B2
(en)
|
2005-06-15 |
2010-01-12 |
Pfizer Inc. |
Substituted arylpyrazoles
|
|
US20080176865A1
(en)
|
2005-06-15 |
2008-07-24 |
Pfizer Limited |
Substituted arylpyrazoles
|
|
GB0517205D0
(en)
|
2005-08-22 |
2005-09-28 |
Novartis Ag |
Organic compounds
|
|
CA2623327A1
(en)
|
2005-10-07 |
2007-04-19 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
|
|
JP5193876B2
(ja)
|
2005-12-02 |
2013-05-08 |
バイエル・ヘルスケア・エルエルシー |
オーロラキナーゼの阻害により癌を処置するために有用なピロロトリアジン誘導体
|
|
KR20080098490A
(ko)
|
2006-01-13 |
2008-11-10 |
파마시클릭스, 인코포레이티드 |
티로신 키나제 억제제 및 이의 용도
|
|
WO2007115269A2
(en)
|
2006-03-31 |
2007-10-11 |
The Board Of Regents Of The University Of Texas System |
Orally bioavailable caffeic acid related anticancer drugs
|
|
US7645748B2
(en)
|
2006-04-03 |
2010-01-12 |
Forbes Medi-Tech Inc. |
Sterol/stanol phosphorylnitroderivatives and use thereof
|
|
US8846697B2
(en)
|
2006-05-31 |
2014-09-30 |
The Regents Of The University Of California |
Purine analogs
|
|
WO2008005954A2
(en)
|
2006-06-30 |
2008-01-10 |
The Board Of Regents Of The University Of Texas System |
Tryphostin-analogs for the treatment of cell proliferative diseases
|
|
RU2481336C2
(ru)
|
2006-07-06 |
2013-05-10 |
Эррэй Биофарма Инк. |
Циклопента(d)пиримидины в качестве ингибиторов протеинкиназ акт
|
|
EP2529621B1
(en)
|
2006-09-22 |
2016-10-05 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
WO2008054827A2
(en)
|
2006-11-03 |
2008-05-08 |
Pharmacyclics, Inc. |
Bruton's tyrosine kinase activity probe and method of using
|
|
AU2007323335A1
(en)
|
2006-11-23 |
2008-05-29 |
Novartis Ag |
Pyrimidines and their use as CXCR2 receptor antagonists
|
|
WO2008116064A2
(en)
|
2007-03-21 |
2008-09-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful for the treatment of proliferative, allergic, autoimmune or inflammatory diseases
|
|
GB2447933A
(en)
|
2007-03-27 |
2008-10-01 |
Chemence Ltd |
Cyanoacrylate monomer for forming an adhesive polymer
|
|
EP2139487B1
(en)
|
2007-03-28 |
2015-11-11 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
ATE522536T1
(de)
|
2008-02-25 |
2011-09-15 |
Hoffmann La Roche |
Pyrrolopyrazin-kinasehemmer
|
|
RU2503676C2
(ru)
|
2008-02-25 |
2014-01-10 |
Ф.Хоффманн-Ля Рош Аг |
Пирролопиразиновые ингибиторы киназы
|
|
CA2722418C
(en)
|
2008-05-13 |
2013-09-17 |
Irm Llc |
Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
|
|
JP2011520986A
(ja)
|
2008-05-22 |
2011-07-21 |
アムジエン・インコーポレーテツド |
タンパク質キナーゼ阻害薬としての複素環類
|
|
CN102159214A
(zh)
|
2008-07-16 |
2011-08-17 |
药品循环公司 |
用于实体肿瘤的治疗的布鲁顿酪氨酸激酶的抑制剂
|
|
RU2011105768A
(ru)
|
2008-08-01 |
2012-09-10 |
Биокрист Фармасьютикалз, Инк. (Us) |
Производные пиперидина в качестве ингибиторов jakз
|
|
US8450337B2
(en)
|
2008-09-30 |
2013-05-28 |
Moleculin, Llc |
Methods of treating skin disorders with caffeic acid analogs
|
|
US20120028981A1
(en)
|
2008-11-05 |
2012-02-02 |
Principia Biopharma Inc. |
Kinase Knockdown Via Electrophilically Enhanced Inhibitors
|
|
US20100113520A1
(en)
|
2008-11-05 |
2010-05-06 |
Principia Biopharma, Inc. |
Kinase knockdown via electrophilically enhanced inhibitors
|
|
US8426428B2
(en)
|
2008-12-05 |
2013-04-23 |
Principia Biopharma, Inc. |
EGFR kinase knockdown via electrophilically enhanced inhibitors
|
|
KR20120063515A
(ko)
|
2009-09-09 |
2012-06-15 |
아빌라 테라퓨틱스, 인크. |
Pi3 키나제 억제제 및 이들의 용도
|
|
US7741330B1
(en)
|
2009-10-12 |
2010-06-22 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
|
|
CN102711765A
(zh)
|
2009-11-16 |
2012-10-03 |
加利福尼亚大学董事会 |
激酶抑制剂
|
|
EP2571880A1
(en)
|
2010-05-20 |
2013-03-27 |
F.Hoffmann-La Roche Ag |
Pyrrolo [2, 3 - b]pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors
|
|
US8940725B2
(en)
|
2010-05-31 |
2015-01-27 |
Ono Pharmaceutical Co., Ltd. |
Purinone derivative
|
|
MX380504B
(es)
|
2010-06-03 |
2025-03-12 |
Pharmacyclics Llc |
El uso de inhibidores de la tirosina quinasa de bruton (btk).
|
|
US20120071497A1
(en)
|
2010-06-03 |
2012-03-22 |
Pharmacyclics, Inc. |
Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinase
|
|
CN101880243A
(zh)
|
2010-06-04 |
2010-11-10 |
贵阳柏丝特化工有限公司 |
一种含氟氰拟除虫菊酯化合物及其合成方法与用途
|
|
PH12013500246A1
(en)
|
2010-08-10 |
2019-10-11 |
Celgene Avilomics Res Inc |
Besylate salt of a btk inhibitor
|
|
BR112013010564B1
(pt)
|
2010-11-01 |
2021-09-21 |
Celgene Car Llc |
Compostos heterocíclicos e composições compreendendo os mesmos
|
|
WO2012158810A1
(en)
|
2011-05-17 |
2012-11-22 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
WO2012158795A1
(en)
|
2011-05-17 |
2012-11-22 |
Principia Biopharma Inc. |
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
|
|
AU2012255860C1
(en)
|
2011-05-17 |
2015-12-10 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
DK2710007T3
(da)
|
2011-05-17 |
2020-01-27 |
Principia Biopharma Inc |
Kinasehæmmere
|
|
US8828426B2
(en)
|
2011-06-07 |
2014-09-09 |
Zx Pharma, Llc |
Multiparticulate L-carnitine compositions and related methods
|
|
WO2013003629A2
(en)
|
2011-06-28 |
2013-01-03 |
Pharmacyclics, Inc. |
Methods and compositions for inhibition of bone resorption
|
|
KR20140048968A
(ko)
|
2011-07-13 |
2014-04-24 |
파마시클릭스, 인코포레이티드 |
브루톤형 티로신 키나제의 억제제
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
WO2013010869A1
(en)
|
2011-07-19 |
2013-01-24 |
Msd Oss B.V. |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors
|
|
CN103889987B
(zh)
|
2011-07-19 |
2016-09-14 |
默沙东有限责任公司 |
作为btk抑制剂的选择的咪唑并吡嗪类
|
|
KR20140063700A
(ko)
|
2011-09-20 |
2014-05-27 |
셀좀 리미티드 |
키나제 억제제로서의 피라졸로[4,3-c]피리딘 유도체
|
|
US20140303191A1
(en)
|
2011-10-19 |
2014-10-09 |
Pharmacyclics, Inc. |
Use of inhibitors of bruton's tyrosine kinase (btk)
|
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
|
US8501724B1
(en)
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
|
MA37711A1
(fr)
|
2012-06-04 |
2017-05-31 |
Pharmacyclics Inc |
Formes cristallines d'un inhibiteur de tyrosine kinase de bruton
|
|
EP2858500A4
(en)
|
2012-06-08 |
2016-04-06 |
Biogen Ma Inc |
BRUTON TYROSINE KINASE HEMMER
|
|
CN104487441B
(zh)
|
2012-06-18 |
2018-06-01 |
普林斯匹亚生物制药公司 |
有用于治疗癌症和自身免疫性疾病的可逆的共价吡咯并嘧啶或吡唑并嘧啶
|
|
WO2014004707A1
(en)
|
2012-06-29 |
2014-01-03 |
Principia Biopharma Inc. |
Formulations comprising ibrutinib
|
|
US20150209432A1
(en)
|
2012-07-26 |
2015-07-30 |
Lupin Limited |
Pharmaceutical compositions of proton pump inhibitor
|
|
US9572811B2
(en)
|
2012-08-03 |
2017-02-21 |
Principia Biopharma Inc. |
Treatment of dry eye
|
|
SMT201900344T1
(it)
|
2012-09-10 |
2019-07-11 |
Principia Biopharma Inc |
Composti di pirazolopirimidina come inibitori di chinasi
|
|
US20150291554A1
(en)
|
2012-11-02 |
2015-10-15 |
Pfizer Inc. |
Bruton's Tyrosine Kinase Inhibitors
|
|
SG11201503459SA
(en)
|
2012-11-02 |
2015-06-29 |
Pharmacyclics Inc |
Tec family kinase inhibitor adjuvant therapy
|
|
KR20150084923A
(ko)
|
2012-11-15 |
2015-07-22 |
파마시클릭스, 인코포레이티드 |
키나제 억제제로서의 피롤로피리미딘 화합물
|
|
US20140142099A1
(en)
|
2012-11-20 |
2014-05-22 |
Principia Biopharma Inc. |
Purinone Derivatives as Tyrosine Kinase Inhibitors
|
|
CN105007940B
(zh)
|
2012-12-20 |
2017-08-25 |
宾夕法尼亚州研究基金会 |
与癌症治疗相关的方法和组合物
|
|
JO3377B1
(ar)
|
2013-03-11 |
2019-03-13 |
Takeda Pharmaceuticals Co |
مشتقات بيريدينيل وبيريدينيل مندمج
|
|
US8957080B2
(en)
|
2013-04-09 |
2015-02-17 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
US20160113913A1
(en)
|
2013-04-19 |
2016-04-28 |
Takeda Pharmaceutical Company Limited |
Controlled-release drug formulation
|
|
SG11201605417QA
(en)
|
2014-02-03 |
2016-08-30 |
Cadila Healthcare Ltd |
Heterocyclic compounds
|
|
KR20160124157A
(ko)
|
2014-02-20 |
2016-10-26 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
인간 인터페론의 유도인자로서의 피롤로[3,2]피리미딘 유도체
|
|
CN112353806A
(zh)
|
2014-02-21 |
2021-02-12 |
普林斯匹亚生物制药公司 |
Btk抑制剂的盐和固体形式
|
|
SG11201704808VA
(en)
|
2014-12-18 |
2017-07-28 |
Principia Biopharma Inc |
Treatment of pemphigus
|
|
HRP20230305T1
(hr)
|
2014-12-24 |
2023-05-26 |
Principia Biopharma Inc. |
Pripravci za ileo-jejunalnu dostavu lijeka
|
|
CN107427468B
(zh)
|
2014-12-24 |
2022-02-25 |
普林斯匹亚生物制药公司 |
Btk抑制剂的部位特异性给药
|
|
EP3912979B1
(en)
|
2015-06-03 |
2026-03-25 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
US20180305350A1
(en)
|
2015-06-24 |
2018-10-25 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
|
CN105753863B
(zh)
|
2015-09-11 |
2018-07-31 |
东莞市真兴贝特医药技术有限公司 |
氧代二氢咪唑并吡啶类化合物及其应用
|
|
US10358446B2
(en)
|
2015-10-14 |
2019-07-23 |
Zibo Biopolar Changsheng Pharmaceutical Co., Ltd. |
Bruton's tyrosine kinase inhibitors
|
|
IL263815B
(en)
|
2016-06-29 |
2022-07-01 |
Principia Biopharma Inc |
Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[4,3-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4 -Methyl-4-[4-(Oxtan-3-yl)piperazin-1-yl)pent-2-ananitrile
|
|
US20210113568A1
(en)
|
2018-04-27 |
2021-04-22 |
Ono Pharmaceutical Co., Ltd. |
PREVENTIVE AND/OR THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASE COMPRISING COMPOUND HAVING Btk INHIBITORY ACTIVITY AS ACTIVE INGREDIENT
|
|
CN110483521B
(zh)
|
2018-05-14 |
2022-06-07 |
杭州和正医药有限公司 |
一种可逆共价布鲁顿酪氨酸激酶抑制剂、药物组合物及其应用
|
|
AU2020365951B2
(en)
|
2019-10-14 |
2026-07-16 |
Principia Biopharma Inc. |
Methods for treating immune thrombocytopenia by administering (R)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
|
|
WO2021150723A1
(en)
|
2020-01-22 |
2021-07-29 |
Principia Biopharma Inc. |
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
|
|
WO2022081512A1
(en)
|
2020-10-12 |
2022-04-21 |
Synubi Pharmaceuticals Llc |
Compositions and methods of treatment of neuroinflammatory diseases with bruton's tyrosine kinase inhibitors
|